Cytek Biosciences (CTKB) Deferred Taxes (2024 - 2026)
Cytek Biosciences (CTKB) posted Deferred Taxes of -$183000.0 for Q1 2026, down 100.47% on a QoQ basis from $38.6 million in Q4 2025, and up 45.54% year-over-year from -$125742.3 in Q1 2025.
Cytek Biosciences (CTKB) Deferred Taxes (2024 - 2026) Analysis & Trends
Cytek Biosciences' Deferred Taxes history runs 3 years deep, the most recent figure standing at -$183000.0 for Q1 2026.
- Quarterly Deferred Taxes rose 45.54% year-over-year to -$183000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.7 million (up 1146.24% YoY) and the FY2025 annual result came in at $33.6 million, up 1262.75% from the prior year.
- Deferred Taxes was -$183000.0 for Q1 2026 at Cytek Biosciences, down from $38.6 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $38.6 million in Q4 2025 and bottomed at -$2.9 million in Q4 2024.
- A 3-year average of $5.1 million and a median of -$1.2 million in 2025 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2025 — Deferred Taxes surged 1436.66% — and 2026, when it surged 45.54%.
- Cytek Biosciences' Deferred Taxes stood at -$2.9 million in 2024, then jumped by 1436.66% to $38.6 million in 2025, then tumbled by 100.47% to -$183000.0 in 2026.
- Business Quant data shows CTKB's Deferred Taxes at -$183000.0 in Q1 2026, $38.6 million in Q4 2025, and -$2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 7.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | -183,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -183,000.00 |
| Dec 31, 2025 | 38.58 Mn |
| Sep 30, 2025 | -2.63 Mn |
| Jun 30, 2025 | -2.06 Mn |
| Mar 31, 2025 | -336,000.00 |
| Dec 31, 2024 | -2.89 Mn |